CKPT Checkpoint Therapeutics Inc. Operatsion rentabellik

checkpointtx.com (CKPT) - korporativ logo

Yassi hujayrali teri saratoni terapiyasi uchun mo'ljallangan antitanalarning bozori yangi yechimlarning mavjudligi tufayli hozirda jadal o'smoqda. EBIT rentabelligi joriy samaradorlikni namoyish etmoqda, bunda parametr qiymati -137500.00 ga yetdi. Checkpoint Therapeutics (CKPT) pozitsiyalari yuqori marjani kafolatlovchi Cosibelimab patentlari bilan mustahkamlanmoqda, TG Therapeutics bilan strategik alyans esa ilg'or onkologik dori vositalarini yaratish uchun ilmiy salohiyatni konsolidatsiya qilish imkonini beradi.

checkpointtx.com (CKPT): Sotuvning operatsion rentabelligi 04.07.2022dan 07.06.2025gacha

Checkpoint Therapeutics, Inc. (CKPT) kompaniyasining tahliliy kesimlari

Fundamental baholash:Checkpoint Therapeutics, Inc
checkpointtx.com asosiy tovari

Barqarorlik omillarini aniqlash uchun investor operatsion foydaning tushumga nisbatini tahlil qiladi, bu esa qarz yuklamasi va soliqlarni hisobga olishdan oldin biznes jarayonlari samaradorligini baholash imkonini beradi. -137500.00 miqdoriga yetgan o'rtacha operatsion marja Checkpoint Therapeutics (CKPT) kompaniyasining dori vositalarini klinik sinov bosqichlaridan muvaffaqiyatli o'tkazishi uchun zarur bo'lgan R&D yadrosini saqlash va yuqori rahbarlikni ishga olish xarajatlarini aks ettiradi.

Checkpoint Therapeutics raqobatchilari tahlili

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Sotuvning operatsion marjasi Sunshine Biopharma, Inc. SBFM|Operatsion marja XBIO (Xenetic Biosciences)|Operatsion foyda normasi SLRX|PPBT - Operatsion rentabellik|AONC (aoncology.com) - Operatsion foyda bo'yicha sotuv rentabelligi|BGNE: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja